Nyxoah SA. | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Nyxoah SA.

BRIEF

published on 11/06/2024 at 22:10, 14 days 12 hours ago

Nyxoah Reports Third Quarter 2024 Financial Results

Financial Results Cash Position FDA Approval Obstructive Sleep Apnea U.S. Commercialization
PRESS RELEASE

published on 11/06/2024 at 22:05, 14 days 12 hours ago

Nyxoah Reports Third Quarter Financial and Operating Results
Nyxoah SA reports third quarter financial and operating results, with FDA approval on track for Q1 2025 and strengthening of U.S. commercial team. Company fully funded until mid-2026

Financial Results FDA Approval Sleep Apnea Nyxoah U.S. Commercial Team
BRIEF

published on 10/08/2024 at 14:05, 1 month 12 days ago

Nyxoah Secures $27 Million in At-the-Market Offering

Financing U.S. Market Nyxoah Neuromodulation Healthcare Investor
PRESS RELEASE

published on 10/08/2024 at 14:00, 1 month 12 days ago

Nyxoah Raises $27 Million through its At-the-Market Offering
Nyxoah raises $27 million through its At-the-Market Offering, strengthening balance sheet and U.S. focus. New investment from U.S. healthcare investor

Financing At-the-market Offering Nyxoah Obstructive Sleep Apnea Healthcare Investor
BRIEF

published on 09/27/2024 at 22:35, 1 month 23 days ago

Nyxoah Presents Promising DREAM Study Data at ISSS 2024

FDA Approval Clinical Data Obstructive Sleep Apnea DREAM Study Genio Stimulation
PRESS RELEASE

published on 09/27/2024 at 22:30, 1 month 23 days ago

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Nyxoah presents DREAM Study results at the International Surgical Sleep Society 2024 Educational Update, showing significant improvements in OSA patients treated with Genio neuromodulation therapy

Clinical Data Nyxoah Obstructive Sleep Apnea DREAM Study Neuromodulation
BRIEF

published on 09/02/2024 at 22:10, 2 months 18 days ago

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

FDA Approval Sleep Apnea Nyxoah U.S. Market Launch Genio® Device
PRESS RELEASE

published on 09/02/2024 at 22:05, 2 months 18 days ago

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
Nyxoah rings the Nasdaq Closing Bell as it prepares for the U.S. market launch of its innovative sleep apnea device, Genio. FDA approval expected by end of 2024

FDA Approval Nasdaq Sleep Apnea Nyxoah Genio
BRIEF

published on 08/06/2024 at 22:10, 3 months 14 days ago

Nyxoah Reports Financial Results for Q2 and H1 2024

Revenue Growth Capital Raise Operational Highlights FDA Submission Q2 2024 Results
PRESS RELEASE

published on 08/06/2024 at 22:05, 3 months 14 days ago

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
Nyxoah SA reports financial and operating results for the second quarter and first half of 2024, including FDA submission completion and U.S. approval progress

Financial Results Operating Results FDA Submission Nyxoah SA U.S. Approval

Accesswire

Published on 11/21/2024 at 10:03, 41 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 44 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 44 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 9 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 19 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 14 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 39 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 42 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 44 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 44 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 46 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 24 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE